We are live on ! Find out more
U

UBS Portfolio holdings

AUM $136B
1-Year Est. Return 16.36%
This Fund
S&P 500
This Quarter Est. Return
-0.23%
1 Year Est. Return
+16.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$136B
AUM Growth
+$7.83B
Cap. Flow
+$3.56B
Cap. Flow %
2.62%
Top 10 Hldgs %
13.26%
Holding
11,505
New
1,064
Increased
4,754
Reduced
3,911
Closed
1,116

Sector Composition

Rank Sector Weight
1 Miscellaneous 47.72%
2 Energy 9.22%
3 Financials 6.8%
4 Healthcare 6.74%
5 Technology 6.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TVTX icon
10101
CALL
Travere Therapeutics
TVTX
$6.15B
$1K ﹤0.01%
100
-3,700
-97% -$43.5K
UAMY icon
10102
CALL
United States Antimony
UAMY
$778M
$1K ﹤0.01%
500
BSIN
10103
PUT
Big Sky Industrial
BSIN
$80.8M
$1K ﹤0.01%
+7
New +$1.66K
VEON icon
10104
PUT
VEON
VEON
$4.42B
$1K ﹤0.01%
4
-4
-50% -$841
WHLR
10105
Wheeler Real Estate Investment Trust
WHLR
$323K
0
WVVI icon
10106
Willamette Valley Vineyards
WVVI
$11.1M
$1K ﹤0.01%
100
WWR icon
10107
PUT
Westwater Resources
WWR
$71.8M
-2
Closed -$3.24K
VBFC
10108
DELISTED
Village Bank and Trust Financial Corp.
VBFC
$1K ﹤0.01%
37
-151
-80% -$3.67K
MMAT
10109
DELISTED
Meta Materials Inc. Common Stock
MMAT
$1K ﹤0.01%
1
-10
-91% -$7.46K
BIOL
10110
CALL
DELISTED
Biolase, Inc.
BIOL
0
MRNS
10111
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$1K ﹤0.01%
+40
New +$1.24K
ACGN
10112
PUT
DELISTED
Aceragen Inc
ACGN
$1K ﹤0.01%
4
SPPI
10113
CALL
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$1K ﹤0.01%
100
-200
-67% -$1.56K
AMBC.WS
10114
DELISTED
Ambac Financial Group
AMBC.WS
$1K ﹤0.01%
102
-1,302
-93% -$19.1K
AHPI
10115
DELISTED
Allied Healthcare Products
AHPI
$1K ﹤0.01%
223
-280
-56% -$1.2K
RBCN
10116
PUT
DELISTED
Rubicon Technology, Inc.
RBCN
$1K ﹤0.01%
+30
New +$2.05K
GPL
10117
DELISTED
Great Panther Mining Limited
GPL
$1K ﹤0.01%
60
-300
-83% -$3.63K
MBII
10118
PUT
DELISTED
Marrone Bio Innovations, Inc.
MBII
$1K ﹤0.01%
+200
New +$1.34K
SBM
10119
DELISTED
ProShares Short Basic Materials
SBM
$1K ﹤0.01%
6
-180
-97% -$22.3K
GNMK
10120
CALL
DELISTED
GenMark Diagnostics, Inc
GNMK
$1K ﹤0.01%
+100
New +$1.08K
GNMK
10121
PUT
DELISTED
GenMark Diagnostics, Inc
GNMK
$1K ﹤0.01%
+100
New +$1.08K
AMAG
10122
DELISTED
AMAG Pharmaceuticals
AMAG
$1K ﹤0.01%
32
-2,914
-99% -$62.1K
ZN
10123
CALL
DELISTED
Zion Oil & Gas, Inc.
ZN
$1K ﹤0.01%
500
-4,200
-89% -$7.91K
ENT
10124
PUT
DELISTED
Global Eagle Entertainment Inc.
ENT
$1K ﹤0.01%
+4
New +$1.16K
ECT
10125
PUT
DELISTED
ECA Marcellus Trust 1 Interest
ECT
$1K ﹤0.01%
100

Similar funds

UBS's Q3 2014 Portfolio in Review

As of Q3 2014, UBS held 11,505 positions worth $136B, up 6.1% from $128B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS's Q3 2014 filing shows 1,064 new, 4,754 increased, 3,911 reduced and 1,116 closed positions. Its largest new stake was Alibaba: 1,105,926 shares worth $98.3M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.62B.

By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, up from 47% a quarter earlier, followed by Energy and Financials.

  • UBS's largest Q3 2014 buy was Alibaba: 1,105,926 shares worth $98.3M.
  • UBS added most to Amgen in Q3 2014, an estimated $387M increase.
  • UBS's biggest Q3 2014 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.62B.
  • UBS fully exited SUSSER HOLDINGS CORPORATION COMMON STOCK in Q3 2014, selling an estimated $81.1M.
  • UBS's ten largest holdings make up 13% of its $136B portfolio in Q3 2014.
  • UBS opened 1,064 new positions and closed 1,116 in Q3 2014.
  • UBS's portfolio value rose 6.1% quarter-over-quarter to $136B.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.